Adanate, Inc
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Phase 1 Study of ADA-011 for Subjects With Advanced Solid Tumors (NCT05601219) | Adanate, Inc | 2022-11-15 |
Track Adanate, Inc automatically
Every clearance here is in the API, with alerts when new ones post.